ArticleBioinformation2025
Prevalence of Non-alcoholic fatty liver disease using fatty liver index (FLI) among health care workers - A cross sectional study.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Healthcare workers (HCWs) have faced increased risk of life-style related disorders such as non-alcoholic fatty liver disease (NAFLD) due to stress and workload following the COVID-19 pandemic. Therefore, it is of interest to evaluate the prevalence of NAFLD and risk factors among 184 Indian HCWs aged over 40 using a non-invasive Fatty Liver Index (FLI) as a diagnostic tool. NAFLD prevalence was 25.7% (95% CI: 19.8-32.5) using an FLI cut-off ≥60, with significant associations found for age, obesity, dyslipidemia, and metabolic syndrome. While no significant association was seen with HbA1c or sex, FLI showed fair agreement with abdominal ultrasonography (kappa = 0.31), supporting its potential as a practical cost-effective tool for large-scale screening rather than a confirmatory diagnostic tool. Given the growing NAFLD burden in high-risk occupational groups, FLI can enable early detection and targeted interventions in HCWs after establishing population-specific cut-off scores.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.